Borthwick Kathleen
CFO
Borthwick Kathleen has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 12, 2026.
On the most recent filing, Borthwick Kathleen is listed as CFO at Passage BIO, Inc. Inside the rolling window, Borthwick Kathleen reported no open-market purchases and 1 open-market sale totaling $38K in PASG.
Companies traded
Other insiders at PASG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$38K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Borthwick Kathleen made?
Borthwick Kathleen has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Borthwick Kathleen trade?
Borthwick Kathleen has filed SEC Form 4 disclosures for 1 company, including PASG.
When was Borthwick Kathleen's most recent SEC Form 4 filing?
Borthwick Kathleen's most recent SEC Form 4 filing on Tracefour is dated Jan 12, 2026.
What is Borthwick Kathleen's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Borthwick Kathleen is listed as CFO.
What is Borthwick Kathleen's total buy and sell value in the current window?
Inside the rolling retention window, Borthwick Kathleen bought $0 and sold $38K based on SEC Form 4 filings.
What was Borthwick Kathleen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,062 PASG shares on 2026-01-08, worth $38K, per SEC Form 4 filings.